Boston— In a significant move that underscores the importance of life science space in Boston’s booming Seaport District, Phase 3 Real Estate Partners, Inc. (P3RE) has announced a new lease agreement with CytoTronics, a cutting-edge biotech firm specializing in semiconductor-based platforms for cell biology research.
The company will occupy 14,000 square feet at GENESIS 12 Farnsworth, a state-of-the-art facility within P3RE’s GENESIS portfolio known for its flexible, high-performance lab and office environments tailored to the life sciences sector.
“As a high-growth startup, it was essential for us to secure a flexible space near the Innovation District, a thriving hub for Boston’s leading tech and biotech companies,” said Jeffrey Abbott, Co-founder and CEO of CytoTronics. “This new location supports our expansion with the necessary lab, office, and manufacturing facilities while also providing an environment that will help us attract and retain top talent.”
Founded as a Harvard University spin-off in 2021, CytoTronics is pioneering a new era in biological discovery. The company’s flagship Pixel platform integrates semiconductors with standard microplates to provide multi-modal electrical, electrochemical, and electrophysiological insights at single-cell resolution. Its applications span cell biology research, drug development, and pharmaceutical manufacturing.
The lease signing highlights the continued strength of the Boston life sciences market, particularly in the Seaport, which has rapidly evolved into a magnet for biotechnology firms seeking cutting-edge infrastructure and proximity to leading academic and medical institutions.
“At Phase 3 Real Estate Partners, we are deeply committed to supporting the life science community by providing best-in-class environments where science and innovation can thrive,” said Morgan Weinstein, Executive Vice President, East Coast at P3RE. “We are incredibly enthusiastic to welcome CytoTronics to GENESIS 12 Farnsworth and look forward to seeing their continued growth and success as they expand their portfolio and bring transformative products to market.”
GENESIS 12 Farnsworth offers premium amenities and adaptable lab configurations that foster collaboration and innovation—an essential feature for startups and established firms alike in the competitive biotech landscape.
The transaction was brokered by CBRE, representing the landlord.
This latest milestone further cements P3RE’s reputation as a top-tier developer in the life sciences sector, delivering dynamic spaces that empower companies to push the boundaries of scientific innovation.
CytoTronics is revolutionizing cell biology with its high-throughput, semiconductor-based platforms. The company’s Pixel systems deliver live-cell data at single-cell resolution across all cell types, unlocking unprecedented capabilities in research and development. Headquartered in Boston, CytoTronics was founded in 2021 out of Harvard University.
